BioGredient II ApS: Financial statements 2023
CVR: 37759724
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BioGredient II ApS (CVR 37759724) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 0 compared with DKK -14,447 the year before. Equity in the 2023 report amounted to DKK -14,447.
- Profit/Loss
- DKK 0
- Equity
- DKK -14,447
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 0 | -14 t. | 0 |
| 2022 | - | - | -14 t. | -14 t. | - |
| 2021 | - | - | 0 | 0 | - |
| 2020 | - | - | 0 | 0 | - |
| 2019 | - | 0 | 0 | 0 | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BioGredient II ApS
BioGredient II ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Nordic-Umami ApS. The company is owned by DACWR ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -14,447.